In cancers, PD-1 binds to PD-L1 or PD-L2 on the surface of tumor cells and/or tumor-associated macrophages (TAMs) in the tumor microenvironment, transducing inhibitory signals to the T-cell receptor (TCR) pathway [3,6]. The gene discussed is PDCD1LG2; the disease is neoplasm.